PAVmed Inc (PAVM)

PAVmed (NASDAQ:PAVM) Raised to Strong-Buy at Lake Street Capital - Defense World

Defense World

PAVmed Inc. (NASDAQ:PAVM) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

PAVmed Inc Provides Informal Financial Performance Update - TipRanks.com - TipRanks

TipRanks

Earnings call: PAVmed discusses Q1 2024 results, subsidiary progress - Investing.com

Investing.com

PAVmed earnings beat by $0.51, revenue fell short of estimates - Investing.com South Africa

Investing.com South Africa

PAVmed Provides Business Update - citybiz

citybiz

PAVmed Provides Business Update and First Quarter 2024 Financial Results - PR Newswire

PR Newswire

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results - Nasdaq

Nasdaq

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall - BioSpace

BioSpace

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall – Company ... - Financial Times

Financial Times

Here's Why PAVmed Inc. (PAVM) Is a Great 'Buy the Bottom' Stock Now - Yahoo News UK

Yahoo News UK

Lucid Diagnostics Appoints Dennis Matheis to Board of Directors - citybiz

citybiz

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis ... - PR Newswire

PR Newswire

PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 - Investing.com India

Investing.com India

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - BioSpace

BioSpace

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - Morningstar

Morningstar

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 - The Malaysian Reserve

The Malaysian Reserve

PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University ... - PR Newswire

PR Newswire

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer ... - BioSpace

BioSpace

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer ... - InvestorsObserver

InvestorsObserver

Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today

Zacks Investment Research

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - PR Newswire

PR Newswire

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

Benzinga

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

New Strong Buy Stocks for March 27th

Zacks Investment Research

PAVmed Full Year 2023 Earnings: EPS Beats Expectations - Yahoo Finance

Yahoo Finance

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results - PR Newswire

PR Newswire

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results - PR Newswire

PR Newswire

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard ... - PR Newswire

PR Newswire

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference - PR Newswire

PR Newswire

PAVmed Inc. Distributes Lucid Stock and Adjusts Warrant Terms - TipRanks.com - TipRanks

TipRanks

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program - PR Newswire

PR Newswire

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device ... - PR Newswire

PR Newswire

PAVmed Inc. Grants Shareholders Lucid Diagnostics Dividend - TipRanks.com - TipRanks

TipRanks

Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9 ... - PR Newswire

PR Newswire

Lucid Diagnostics Issues Stock for PAVmed Compensation - TipRanks.com - TipRanks

TipRanks

PAVmed Inc Acquires Lucid Shares to Settle Debt - TipRanks.com - TipRanks

TipRanks

Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%? - Simply Wall St

Simply Wall St

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Benzinga

The 3 Most Undervalued Penny Stocks to Buy in December - InvestorPlace

InvestorPlace

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies - PR Newswire

PR Newswire

PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders - PR Newswire

PR Newswire

Shareholders in PAVmed (NASDAQ:PAVM) have lost 88%, as stock drops 30% this past week - Simply Wall St

Simply Wall St

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential - InvestorPlace

InvestorPlace

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split - PR Newswire

PR Newswire

Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts - PR Newswire

PR Newswire

PAVmed Provides Business Update and Third Quarter Financial Results - PR Newswire

PR Newswire

Lucid Diagnostics introduces new EsoGuard 2.0 DNA test - Medical Device Network

Medical Device Network

Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day - PR Newswire

PR Newswire